Skip to main content

Lynne M. Laube

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Lynne M. Laube

Lynne M. Laube was last confirmed as Board Member and COO at Cardlytics, Inc. (CDLX) in a filing dated April 20, 2020. Earlier roles on record: CEO at Cardlytics, Inc. (CDLX) until September 1, 2022. Cardlytics, Inc. reported in an 8-K filed July 20, 2022 that Lynne M. Laube resigned as Chief Executive Officer, effective September 1, 2022. The proxy statement of Cardlytics, Inc. reports total compensation of $8,105,384 for Lynne M. Laube in fiscal 2022, including a base salary of $443,125. Disclosed compensation is on record for 5 fiscal years.

“On July 15, 2022, Lynne M. Laube notified the Company of her intent to resign as the Company's Chief Executive Officer, effective as of September 1, 2022 (the "Transition Date"), and that Ms. Laube would remain employed in an advisory capacity to support a transition of responsibilities through May 31, 2024.”
Cardlytics, Inc. Form 8-K, filed July 20, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Cardlytics, Inc. (CDLX) $443,125 $8,105,384
2021 Cardlytics, Inc. (CDLX) $460,000 $6,625,395
2020 Cardlytics, Inc. (CDLX) $362,500 $5,773,600
2019 Cardlytics, Inc. (CDLX) $300,000 $3,816,506
2018 Cardlytics, Inc. (CDLX) $280,000 $2,121,611

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.